Schellenberg Wittmer assisted AOP Orphan Pharmaceuticals on its recent license agreement with Eagle Pharmaceuticals regarding U.S. rights for Landiolol, a beta blocker.
The team of Schellenberg Wittmer consisted of Philipp Groz and Prof. Dr. Peter Georg Picht (both Intellectual Property and Life Sciences) as well as Roland Mathys and Amalie Wijesundera (both Data Protection).
08.10.2024
07.10.2024
26.09.2024